- Home
- KWE vs PBM Comparison
KWE vs PBM Comparison
Compare KWE & PBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KWE
- PBM
- Stock Information
- Founded
- KWE 2017
- PBM 1994
- Country
- KWE Canada
- PBM Canada
- Employees
- KWE N/A
- PBM N/A
- Industry
- KWE
- PBM
- Sector
- KWE
- PBM
- Exchange
- KWE Nasdaq
- PBM NYSE
- Market Cap
- KWE 2.3M
- PBM 4.0M
- IPO Year
- KWE N/A
- PBM N/A
- Fundamental
- Price
- KWE $0.14
- PBM $0.19
- Analyst Decision
- KWE
- PBM
- Analyst Count
- KWE 0
- PBM 0
- Target Price
- KWE N/A
- PBM N/A
- AVG Volume (30 Days)
- KWE 1.5M
- PBM 2.5M
- Earning Date
- KWE 08-16-2024
- PBM 11-02-2024
- Dividend Yield
- KWE N/A
- PBM N/A
- EPS Growth
- KWE N/A
- PBM N/A
- EPS
- KWE N/A
- PBM N/A
- Revenue
- KWE $1,132,395.00
- PBM N/A
- Revenue This Year
- KWE $817.82
- PBM N/A
- Revenue Next Year
- KWE N/A
- PBM N/A
- P/E Ratio
- KWE N/A
- PBM N/A
- Revenue Growth
- KWE 75.25
- PBM N/A
- 52 Week Low
- KWE $0.13
- PBM $0.18
- 52 Week High
- KWE $1.92
- PBM $14.55
- Technical
- Relative Strength Index (RSI)
- KWE 35.11
- PBM 19.33
- Support Level
- KWE $0.14
- PBM $0.40
- Resistance Level
- KWE $0.17
- PBM $0.56
- Average True Range (ATR)
- KWE 0.02
- PBM 0.05
- MACD
- KWE 0.01
- PBM -0.03
- Stochastic Oscillator
- KWE 14.55
- PBM 2.52
About KWE KWESST Micro Systems Inc.
KWESST Micro Systems Inc develops and commercializes next-generation tactical systems. The company offers breakthrough technology in lethal and non-lethal systems with broad application, including law enforcement and personal defence, modernized digitization of tactical forces for shared situational awareness and targeting, and counter-measures against threats such as drones, lasers and electronic detection.
About PBM PSYENCE BIOMEDICAL LTD
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.